The
global mixed tocopherols market is expected to reach USD
11.94billion by 2025, according to a new report by Grand View Research,
Inc.Rising vitamin E demand in food and dietary supplements owing to rising
health concerns is expected to plays a significant role in promoting the
industry growth over the next few years. The global market is anticipated to
observe sluggish growth at a CAGR of 2.4% from 2017 to 2025.
U.S. mixed tocopherols market volume by product, 2014 - 2025 (Tons) |
Alpha
rich tocopherols was the leading product segment and is anticipated to grow at
a CAGR of 2.3%, by revenue, over the forecast period. The segment is expected
to gain share over the forecast period owing to high demand in dietary supplements.
Health benefits associated with vitamin E to treat deficiency and diseases such
as lung, oral, colorectal and pancreatic cancer; polyps, and gastric are also
anticipated to drive the mixed tocopherols market in pharmaceuticals over the
forecast period.
Browse full
research report on Mixed Tocopherols Market: www.grandviewresearch.com/industry-analysis/mixed-tocopherols-industry
Further
Key Findings From the Study Suggest:
- The global mixed tocopherols demand was117.8
kilo tons in 2016 and is estimated to grow at a CAGR of 3.6% from 2017 to
2025
- Mixed tocopherols demand in dietary supplements
was 50.9 kilo tons in 2016 and is anticipated to witness moderate growth
over the next eight years
- Product demand in animal feed nutritionis
anticipated to emerge as the fastest growing application segment, and
generate revenues worth over USD 2 billion by 2025
- Mixed tocopherolsindustry valuation in North
America is projected to reach USD 3.60 billion by 2025 and is estimated to
grow as a significant rate from 2017 to 2025
- The U.S. gamma rich tocopherols demand is
anticipated to emerge as the fastest growing market in North America and
is expected to reach total volume of over 5.6 kilo tons by 2025
- The industry in Europeis projected to witness
moderate growth of 2.9% from 2017 to 2025 owing to the increased use of
mixed tocopherols as antioxidants and feed additives
- Asia Pacific was the dominant consumer in 2016.
High rate of dietary supplements, animal feed, and pharmaceuticals
manufacturing in key economies including China, Japan, and India is the
major factor for industry penetration.
- Key industry participants such asBASF, DSM,
ADM,and Cargill dominated the global mixed tocopherol market over the next
few years. The major players operating in the mixed tocopherol market
comprise, BTSA, Vitae Naturals, Zhejiang Medicine Co., Ltd. (ZMC), COFCO
Tech Bioengineering Co., Ltd., Eisai Food & Chemical Co., Ltd., and
Vance Group Ltd.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/food-additives-nutricosmetics-flavors-and-fragrances
Grand View Research has segmented the global mixed tocopherols market on
the basis of product, application, and region:
Product
Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
- Alpha
Rich
- Gamma
Rich
- Gamma-Delta
Rich
- Others
Application
Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
- Dietary
Supplements
- Animal
Feed Nutrition
- Cosmetics
- Pharmaceuticals
- Food
& Beverage Fortification
Regional
Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Asia
Pacific
- China
- India
- Central
& South America
- Middle
East & Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-mixed-tocopherols-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company, registered
in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment